BioLinker develops and manufactures molecular biology products, viral antigens, and bio-inputs. Their solutions serve the diagnostics, applied research, food industry, and pharmaceuticals sectors.
Founded
2018
Total Funding
$1M+
Total Rounds
1
First Raise
Oct 6, 2026
Latest Raise
Oct 6, 2026
New funding rounds in your inbox every week 路 No noise, all Signal.
Founders and leadership hierarchy for this company.
| Date | Deal Type | Amount | Lead Investor |
|---|---|---|---|
| 10/6/2026 | |||
Upgrade to Premium to view Capital Momentum Score and performance metrics
New funding rounds in your inbox every week 路 Free